Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.35    -0.10 (-0.61%)
Bid:
16.30
Ask:
16.45
Spread: 0.15 (0.92%)
Market Cap: £131.05m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Full Year Trading Update

26 Jun 2012 07:00

RNS Number : 1056G
Allocate Software PLC
26 June 2012
 



ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

 

Full Year Trading Update

 

Allocate Software (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, announces an update on trading for its financial year ended 31 May 2012. The Company's final results will be announced in the week commencing 30 July 2012.

 

Highlights

 

§ Strong financial performance in the year with results expected to be in line with market expectations.

 

§ Healthcare had another successful year securing new customers across the NHS, in the UK private healthcare sector and overseas.

 

§ Completed two acquisitions in the financial year: Zircadian in the UK and RosterOn in Australia. Both performed in line with expectations and the cross-sell of different products into the customer base is beginning to yield encouraging results.

 

§ Defence had a record year, with major contract wins worldwide including the multi million pound agreement with the Australian Defence Forces.

 

Healthcare

 

Because of the drive in the NHS for efficiency and cost savings, market appetite for the Allocate application suite with its proven ROI remained strong, with new customers, new products, licence renewals and extensions. HealthRoster, our e-rostering product, retained its strong competitive position and was selected in the majority of all competitive tenders in the UK during the fiscal year.

 

The release of v10, the fully web-based version of HealthRoster with multi-language capability, positions this product well for further internationalisation. Our Swedish business, Time Care, has again performed well and met expectations as it has now done every year since acquisition. HealthRoster will be available in Swedish as the first internationalisation of HealthRoster in the coming months.

 

Leveraging acquisitions - the integration of HealthRoster and the Zircadian products with the rest of the Allocate suite of products provides customers with an end to end solution from planning to scheduling of the medical workforce. In addition, the integration of HealthRoster and the RosterOn product has created a bespoke leading employment awards interpretation engine for the Australian market. The broadening of our product range is creating significant cross-sell opportunities, in line with our strategy.

 

Defence

 

The Defence business achieved substantial growth and continued diversifying into other geographic regions, generating significant business from overseas. Highlights include:

 

§ Securing a multi-million pound licence contract with the Australian Defence Department extending the use of Defence Suite across the Army, Navy and civilians under military control.

§ Substantial additional Consultancy Services contract extension wins with the Royal Australian Navy, as part of their New Generation Navy programme.

§ Two new Consultancy Services contract wins in NATO within their Force Operations Group, and Special Forces HQ.

§ Extension of the UK Army Support contract to 2014

 

Maritime

 

§ Secured a new licence agreement with McDermott Inc, a major US offshore engineering company, the third in this sector

§ Completed a major Maritime Suite implementation to support SubSea7's global Offshore Oil Services operations

 

 

Ian Bowles, Chief Executive Officer of Allocate commented: "Despite the global economic environment and the macro economics of UK government spending we have executed well in our industry sectors and I am delighted with the performance of Allocate this year, particularly in the second half.

 

"2012 was our sixth consecutive year of record revenue. This consistency of execution, I believe, demonstrates a balance across our business, both in terms of vertical markets and geographical focus, which speaks well to our plans for significant growth over the next three to five years. I am very pleased with this year's performance and look forward to Allocate's continued success in the next financial year".

 

 

Enquiries:

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Michael Meade / Simon Willis/ Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James / John Bick

 

Tel: +44 (0) 20 7193 7463

M: +44 (0) 7525 324431

 

About Allocate Software plc

Allocate Software plc is the leading workforce optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

 

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRNRUOANUAR
Date   Source Headline
20th Nov 20077:01 amRNSChange of Adviser
8th Nov 200710:08 amRNSHolding(s) in Company
7th Nov 20071:34 pmRNSAward of Contract
5th Nov 20073:00 pmRNSDirector/PDMR Shareholding
18th Oct 200712:08 pmRNSRe Contract
27th Sep 20075:18 pmRNSHolding(s) in Company
27th Sep 20073:30 pmRNSAward of contract
20th Sep 20073:15 pmRNSAward of Contract
19th Sep 200711:31 amRNSHolding(s) in Company
19th Sep 20079:02 amRNSDirector/PDMR Shareholding
5th Sep 200710:25 amRNSHolding(s) in Company
23rd Aug 20071:47 pmRNSAward of Contract
17th Aug 200711:59 amRNSHolding(s) in Company
6th Aug 20071:00 pmRNSAward of Contract
31st Jul 20077:01 amRNSDirector/PDMR Shareholding
30th Jul 200712:29 pmRNSCompany Website
30th Jul 20077:00 amRNSFinal Results
1st Jun 20073:13 pmRNSTotal Voting Rights
23rd May 200712:58 pmRNSIssue of Equity
22nd May 20079:11 amRNSCEO Appointment Confirmed
22nd May 20077:01 amRNSAcquisition
2nd May 20078:50 amRNSIssue of Equity
26th Apr 20079:13 amRNSTrading Update
20th Apr 20072:32 pmRNSHolding(s) in Company
19th Apr 20077:00 amRNSDirector/PDMR Shareholding
17th Apr 20079:34 amRNSDirector/PDMR Shareholding
30th Mar 20073:49 pmRNSIssue of Equity
27th Mar 20073:09 pmRNSDirector/PDMR Shareholding
27th Mar 20072:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20075:06 pmRNSHolding(s) in Company
20th Mar 200710:00 amRNSDirectorate Change
13th Mar 20074:28 pmRNSHolding(s) in Company
1st Mar 200712:55 pmRNSHolding(s) in Company
22nd Feb 20079:16 amRNSHolding(s) in Company
22nd Feb 20079:12 amRNSHolding(s) in Company
19th Feb 200712:04 pmRNSDirector/PDMR Shareholding
19th Feb 200712:03 pmRNSHolding(s) in Company
19th Feb 200712:00 pmRNSHolding(s) in Company
16th Feb 20074:28 pmRNSDirector/PDMR Shareholding
15th Feb 20074:41 pmRNSDirector/PDMR Shareholding
15th Feb 20073:03 pmRNSHolding(s) in Company
15th Feb 20077:01 amRNSInterim Results
9th Feb 20073:58 pmRNSIssue of Equity
9th Feb 20079:55 amRNSHolding(s) in Company
17th Jan 20079:15 amRNSBoard Change
19th Dec 200610:15 amRNSTotal Voting Rights
18th Dec 20063:31 pmRNSDirectorate Change & AGM
8th Dec 20069:17 amRNSHolding(s) in Company
7th Dec 20064:13 pmRNSHolding(s) in Company
5th Dec 20067:01 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.